Skip to Main Content

Paper Details

Impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccination and Booster on Coronavirus Disease 2019 (COVID-19) Symptom Severity Over Time in the COVID-OUT Trial.
Clin Infect Dis
6
2023
COVID, COVID-19, Participants, SARS, SARS-CoV, SARS-CoV-2, chills, cough, diarrhea, fatigue, fever, fluvoxamine, headache, ivermectin, metformin, myalgia, nausea, participants, smell and taste abnormalities
Author NameAffiliation
David R BoulwareUniversity of Minnesota
Christopher J TignanelliUniversity of Minnesota
John B BuseUniversity of North Carolina
David LiebovitzNorthwestern University Feinberg School of Medicine
Michael A PuskarichUniversity of Minnesota
Michael A PuskarichHennepin County Medical Center
Nicholas E IngrahamUniversity of Minnesota
Adnin ZamanUniversity of Colorado-Anschutz Medical Campus
Nancy E SherwoodSchool of Public Health, University of Minnesota
Carolyn T BramanteUniversity of Minnesota
  • 1 - 10

Datasets

Release 1.2